Intra-arterial Allogeneic Mesenchymal Stem Cells for Critical Limb Ischemia are Safe and Efficacious: Report of a Phase I Study

go back to reference Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113:e463–e654 Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113:e463–e654

go back to reference Anon (1996) Critical limb ischaemia: management and outcome. Report of a National Survey: The Vascular Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg 12:131–135CrossRef Anon (1996) Critical limb ischaemia: management and outcome. Report of a National Survey: The Vascular Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg 12:131–135CrossRef

go back to reference Watt SM, Athanassopoulos A, Harris AL et al (2010) Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J R Soc Interface 7(Suppl 6):S731–S751PubMedCrossRef Watt SM, Athanassopoulos A, Harris AL et al (2010) Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J R Soc Interface 7(Suppl 6):S731–S751PubMedCrossRef

go back to reference El Oakley RM, Seow KK, Tang TPL et al (2002) Whole bone marrow transplantation induces angiogenesis following acute ischemia. Redox Rep 7(4):215–218PubMedCrossRef El Oakley RM, Seow KK, Tang TPL et al (2002) Whole bone marrow transplantation induces angiogenesis following acute ischemia. Redox Rep 7(4):215–218PubMedCrossRef

go back to reference Iba O, Matsubara H, Nozawa Y et al (2002) Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106(15):2019–2025PubMedCrossRef Iba O, Matsubara H, Nozawa Y et al (2002) Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106(15):2019–2025PubMedCrossRef

go back to reference Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97(7):3422–3427PubMedCrossRef Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97(7):3422–3427PubMedCrossRef

go back to reference Murphy MP, Lawson JH, Rapp BM et al (2011) Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg 53:1565–1574PubMedCrossRef Murphy MP, Lawson JH, Rapp BM et al (2011) Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg 53:1565–1574PubMedCrossRef

go back to reference Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147PubMedCrossRef Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147PubMedCrossRef

go back to reference Tse WT, Pendleton JD, Beyer WM et al (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75(3):389–397PubMedCrossRef Tse WT, Pendleton JD, Beyer WM et al (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75(3):389–397PubMedCrossRef

go back to reference Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838–3843PubMedCrossRef Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838–3843PubMedCrossRef

go back to reference U.S. Food and Drug Administration, CFR Code of Federal Regulations Title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=640. Accessed 5 Feb 2011 U.S. Food and Drug Administration, CFR Code of Federal Regulations Title 21. http://​www.​accessdata.​fda.​gov/​scripts/​cdrh/​cfdocs/​cfcfr/​CFRSearch.​cfm?​CFRPart=​640. Accessed 5 Feb 2011

go back to reference Walter DH, Krankenberg H, Balzer JO et al (2011) Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 4:26–37PubMedCrossRef Walter DH, Krankenberg H, Balzer JO et al (2011) Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 4:26–37PubMedCrossRef

go back to reference Tateishi-Yuyama E, Matsubara H, Murohara T et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427–435PubMedCrossRef Tateishi-Yuyama E, Matsubara H, Murohara T et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427–435PubMedCrossRef

go back to reference Esato K, Hamano K, Li TS et al (2002) Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 11:747–752PubMed Esato K, Hamano K, Li TS et al (2002) Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 11:747–752PubMed

go back to reference Miyamoto M, Yasutake M, Takano H et al (2004) Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transpl 13:429–437CrossRef Miyamoto M, Yasutake M, Takano H et al (2004) Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transpl 13:429–437CrossRef

go back to reference Saigawa T, Kato K, Ozawa T et al (2004) Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 68:1189–1193PubMedCrossRef Saigawa T, Kato K, Ozawa T et al (2004) Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 68:1189–1193PubMedCrossRef

go back to reference Iafrati MD, Hallett JW, Geils G et al (2011) Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg 54(6):1650–1658PubMedCrossRef Iafrati MD, Hallett JW, Geils G et al (2011) Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg 54(6):1650–1658PubMedCrossRef

go back to reference Levine JE, Harris RE, Loberiza FR et al (2003) A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101(7):2476–2482PubMedCrossRef Levine JE, Harris RE, Loberiza FR et al (2003) A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101(7):2476–2482PubMedCrossRef

go back to reference Van Tongeren RB, Hamming JF, Fibbe WE et al (2008) Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovas Surg 49:51–58 Van Tongeren RB, Hamming JF, Fibbe WE et al (2008) Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovas Surg 49:51–58

go back to reference Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M et al (2011) Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transpl 20:1629–1639CrossRef Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M et al (2011) Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transpl 20:1629–1639CrossRef

go back to reference Schiavetta A, Maione C, Botti C et al (2012) A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure evaluation of stem cells study. Stem Cells Trans Med 1:572–578CrossRef Schiavetta A, Maione C, Botti C et al (2012) A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure evaluation of stem cells study. Stem Cells Trans Med 1:572–578CrossRef